Acidic Extracellular pH Induces Vascular Endothelial Growth Factor (VEGF) in Human Glioblastoma Cells via ERK1/2 MAPK Signaling Pathway
暂无分享,去创建一个
R. Jain | D. Fukumura | Lei Xu
[1] R K Jain,et al. Hypoxia and acidosis independently up-regulate vascular endothelial growth factor transcription in brain tumors in vivo. , 2001, Cancer research.
[2] J. Abbruzzese,et al. Regulation of vascular endothelial growth factor expression by acidosis in human cancer cells , 2001, Oncogene.
[3] M. Karin,et al. Mammalian MAP kinase signalling cascades , 2001, Nature.
[4] M. Karin,et al. The stress-induced MAP kinase p38 regulates endocytic trafficking via the GDI:Rab5 complex. , 2001, Molecular cell.
[5] M. S. Lee,et al. Hypoglycemia-induced VEGF expression is mediated by intracellular Ca2+ and protein kinase C signaling pathway in HepG2 human hepatoblastoma cells. , 2001, International journal of molecular medicine.
[6] R K Jain,et al. Vascular endothelial growth factor (VEGF) modulation by targeting hypoxia-inducible factor-1alpha--> hypoxia response element--> VEGF cascade differentially regulates vascular response and growth rate in tumors. , 2000, Cancer research.
[7] R. Nagai,et al. Induction of VEGF gene transcription by IL-1 beta is mediated through stress-activated MAP kinases and Sp1 sites in cardiac myocytes. , 2000, Journal of molecular and cellular cardiology.
[8] J. Abbruzzese,et al. Regulation of interleukin-8 expression by cellular pH in human pancreatic adenocarcinoma cells. , 2000, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[9] P. Carmeliet,et al. Angiogenesis in cancer and other diseases , 2000, Nature.
[10] I. Fidler,et al. Acidic pH-induced elevation in interleukin 8 expression by human ovarian carcinoma cells. , 2000, Cancer research.
[11] W. Zhou,et al. Investigation of the mechanism of action of microperoxidase-11, (MP11), a potential anti-cataract agent, with hydrogen peroxide and ascorbate. , 2000, Experimental eye research.
[12] P. Wesseling,et al. Amyloid‐β‐induced Degeneration of Human Brain Pericytes Is Dependent on the Apolipoprotein E Genotype , 2000, Annals of the New York Academy of Sciences.
[13] D. Mottet,et al. ERK activation upon hypoxia: involvement in HIF‐1 activation , 2000, FEBS letters.
[14] F. Facchiano,et al. Acidosis inhibits endothelial cell apoptosis and function and induces basic fibroblast growth factor and vascular endothelial growth factor expression. , 2000, Circulation research.
[15] M. Kuwano,et al. Mitogen-activated protein kinase, ERK1/2, is essential for the induction of vascular endothelial growth factor by ionizing radiation mediated by activator protein-1 in human glioblastoma cells , 2000, Free radical research.
[16] I. Fidler,et al. Hypoxia-induced elevation in interleukin-8 expression by human ovarian carcinoma cells. , 1999, Cancer research.
[17] J. Ferrell,et al. The protein kinase p90 rsk as an essential mediator of cytostatic factor activity. , 1999, Science.
[18] J. Pouysségur,et al. p42/p44 Mitogen-activated Protein Kinases Phosphorylate Hypoxia-inducible Factor 1α (HIF-1α) and Enhance the Transcriptional Activity of HIF-1* , 1999, The Journal of Biological Chemistry.
[19] N. Ferrara. Role of vascular endothelial growth factor in the regulation of angiogenesis. , 1999, Kidney international.
[20] D. Hanahan,et al. Tumor-derived expression of vascular endothelial growth factor is a critical factor in tumor expansion and vascular function. , 1999, Cancer research.
[21] A. Brunet,et al. Nuclear translocation of p42/p44 mitogen‐activated protein kinase is required for growth factor‐induced gene expression and cell cycle entry , 1999, The EMBO journal.
[22] C. Marshall,et al. Activated MEK Stimulates Expression of AP-1 Components Independently of Phosphatidylinositol 3-Kinase (PI3-Kinase) but Requires a PI3-Kinase Signal To Stimulate DNA Synthesis , 1999, Molecular and Cellular Biology.
[23] H. Dvorak,et al. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. , 1999, Current topics in microbiology and immunology.
[24] R. Xavier,et al. Tumor Induction of VEGF Promoter Activity in Stromal Cells , 1998, Cell.
[25] R G Blasberg,et al. Tumor growth modulation by sense and antisense vascular endothelial growth factor gene expression: effects on angiogenesis, vascular permeability, blood volume, blood flow, fluorodeoxyglucose uptake, and proliferation of human melanoma intracerebral xenografts. , 1998, Cancer research.
[26] T. Kizaki,et al. Tissue distribution of immunoreactive mouse extracellular superoxide dismutase. , 1998, American journal of physiology. Cell physiology.
[27] A. Brunet,et al. Growth Factor–induced p42/p44 MAPK Nuclear Translocation and Retention Requires Both MAPK Activation and Neosynthesis of Nuclear Anchoring Proteins , 1998, The Journal of cell biology.
[28] F. Hobbs,et al. Identification of a Novel Inhibitor of Mitogen-activated Protein Kinase Kinase* , 1998, The Journal of Biological Chemistry.
[29] S. Leung,et al. Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma. , 1998, The American journal of surgical pathology.
[30] E. Goldsmith,et al. Phosphorylation of the MAP Kinase ERK2 Promotes Its Homodimerization and Nuclear Translocation , 1998, Cell.
[31] Robert S. Kerbel,et al. Establishing a Link between Oncogenes and Tumor Angiogenesis , 1998, Molecular medicine.
[32] I. Tannock,et al. Heterogeneity of intracellular pH and of mechanisms that regulate intracellular pH in populations of cultured cells. , 1998, Cancer research.
[33] G. Semenza,et al. V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression. , 1997, Cancer research.
[34] A. Giaccia,et al. Induction of vascular endothelial growth factor by hypoxia is modulated by a phosphatidylinositol 3-kinase/Akt signaling pathway in Ha-ras-transformed cells through a hypoxia inducible factor-1 transcriptional element. , 1997, Blood.
[35] W. Risau,et al. Activator-protein-1 binding potentiates the hypoxia-induciblefactor-1-mediated hypoxia-induced transcriptional activation of vascular-endothelial growth factor expression in C6 glioma cells. , 1997, The Biochemical journal.
[36] P. Baeuerle,et al. Hypoxia Induces c-fos Transcription via a Mitogen-activated Protein Kinase-dependent Pathway* , 1997, The Journal of Biological Chemistry.
[37] G. Siemeister,et al. Sp1 recognition sites in the proximal promoter of the human vascular endothelial growth factor gene are essential for platelet-derived growth factor-induced gene expression , 1997, Oncogene.
[38] R. Swerlick,et al. Transforming growth factor‐α‐induced transcriptional activation of the vascular permeability factor (VPF/VEGF) gene requires AP‐2‐dependent DNA binding and transactivation , 1997, The EMBO journal.
[39] Rakesh K. Jain,et al. Interstitial pH and pO2 gradients in solid tumors in vivo: High-resolution measurements reveal a lack of correlation , 1997, Nature Medicine.
[40] R K Jain,et al. Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[41] Masahiko Hibi,et al. c-Jun Can Recruit JNK to Phosphorylate Dimerization Partners via Specific Docking Interactions , 1996, Cell.
[42] M. Karin,et al. The Ras-JNK pathway is involved in shear-induced gene expression , 1996, Molecular and cellular biology.
[43] G. Semenza,et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1 , 1996, Molecular and cellular biology.
[44] R. Treisman,et al. Regulation of transcription by MAP kinase cascades. , 1996, Current opinion in cell biology.
[45] E. Nishida,et al. Roles of the MAP kinase cascade in vertebrates. , 1996, Advances in pharmacology.
[46] C. Der,et al. Activation of Rac1, RhoA, and mitogen-activated protein kinases is required for Ras transformation , 1995, Molecular and cellular biology.
[47] D. Marmé,et al. Both v-Ha-Ras and v-Raf Stimulate Expression of the Vascular Endothelial Growth Factor in NIH 3T3 Cells (*) , 1995, The Journal of Biological Chemistry.
[48] D. Shima,et al. Hypoxic induction of vascular endothelial growth factor (VEGF) in human epithelial cells is mediated by increases in mRNA stability , 1995, FEBS letters.
[49] M. Karin. The Regulation of AP-1 Activity by Mitogen-activated Protein Kinases (*) , 1995, The Journal of Biological Chemistry.
[50] T. Hunter,et al. Transcriptional control by protein phosphorylation: signal transmission from the cell surface to the nucleus , 1995, Current Biology.
[51] M. Wigler,et al. Multiple ras functions can contribute to mammalian cell transformation , 1995, Cell.
[52] J. Caro,et al. Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo. , 1994, Laboratory investigation; a journal of technical methods and pathology.
[53] J. Moringlane,et al. Detection and quantification of vascular endothelial growth factor/vascular permeability factor in brain tumor tissue and cyst fluid: the key to angiogenesis? , 1994, Neurosurgery.
[54] C. Marshall,et al. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells , 1994, Cell.
[55] J. Fiddes,et al. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. , 1991, The Journal of biological chemistry.
[56] M. Karin,et al. Different requirements for formation of Jun: Jun and Jun: Fos complexes. , 1989, Genes & development.
[57] I. Tannock,et al. Acid pH in tumors and its potential for therapeutic exploitation. , 1989, Cancer research.
[58] J. Haveman,et al. The relevance of tumour pH to the treatment of malignant disease. , 1984, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.